Lund University

lu.se

Matched: Lund University Hospital · Lund University

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

293

Active

54

Phase 3

14

Total enrollment

188,230

Pipeline matrix

Showing 13 of 13 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
177Lu-DOTATOC1
Capecitabine1
Pivmecillinam and amoxicillin/clavulanic acid1
Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility1
epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab1
epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab1
Simvastatin 40mg1
Fluorouracil1
Oxaliplatin1
Irinotecan1
Pemigatinib1
Retifanlimab1
Active medication1

Next readouts

  • 2024-05-31
  • 2026-10-01
  • 2026-11-30
  • 2027-01-26
  • 2027-09-01
  • 2027-12-31
  • 2035-09

Top conditions

  • Healthy10
  • Type 2 Diabetes10
  • Obesity10
  • Metabolic Syndrome8
  • Celiac Disease in Children5
  • Breast Cancer5
  • Healthy Subjects5
  • Athletic Injuries4

Frequently asked questions about Lund University

How many clinical trials does Lund University have on ClinicalTrials.gov?
Lund University is listed as the lead sponsor on 293 clinical trials in ClinicalTrials.gov, 54 of which are currently active (recruiting, enrolling, or ongoing).
How many of Lund University's trials are in Phase 3?
14 of Lund University's trials are in Phase 3, spread across 13 active drug programs.
What therapeutic areas does Lund University focus on?
Lund University's most-studied conditions on ClinicalTrials.gov are Healthy, Type 2 Diabetes, Obesity, Metabolic Syndrome, Celiac Disease in Children.
When are Lund University's next clinical trial readouts?
Lund University has 7 upcoming primary-completion readouts tracked here; the soonest is “Acoustic and Vestibular Noise as Possible Non-pharmacological Treatment of ADHD in School Children”, expected around 2024-05-31.